Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Non-Small Cell Lung CancerElectroacupunctureImmune Checkpoint Inhibitors
Interventions
OTHER

Electroacupuncture combined with immunotherapy

Connect the electroacupuncture therapy instrument, select the density wave 2 Hz/100 Hz, the current intensity should be tolerated by the patient, leave the needle for 20 min.Immunotherapy including but not limited to pabolizumab and attilizumab were repeated every 21 days for treatment weeks.The period is 1 year, and maintenance treatment can be carried out in accordance with the drug instructions and guidelines.

DRUG

Zilongjin tablet combined with immunotherapy

Take Zilongjin tablets orally, 4 tablets each time, 3 times a day.Immunotherapy including but not limited to pabolizumab and attilizumab were repeated every 21 days for treatment weeks.The period is 1 year, and maintenance treatment can be carried out in accordance with the drug instructions and guidelines.

DRUG

Immunotherapy

Immunotherapy including but not limited to pabolizumab and attilizumab were repeated every 21 days for treatment weeks.The period is 1 year, and maintenance treatment can be carried out in accordance with the drug instructions and guidelines.

Trial Locations (1)

300381

RECRUITING

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

All Listed Sponsors
collaborator

Ministry of Science and Technology of the People´s Republic of China

OTHER_GOV

lead

Kong Fanming

OTHER